Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Thrombosis and Haemostasis|December 23, 2025
Atrial Fibrillation in Philadelphia Chromosome-negative Myeloproliferative Neoplasms: Thromboinflammatory Crosstalk with a Focus on the NLRP3 InflammasomeOlga Demska, Marta Szandruk-Bender, Niels Eske Bruun, et al.
International Journal of Molecular Sciences|June 14, 2020
Profound Nanoscale Structural and Biomechanical Changes in DNA Helix upon Treatment with Anthracycline DrugsAleksandra Kaczorowska, Weronika Lamperska, Kaja Frączkowska, et al.
Thrombosis and Haemostasis|May 13, 2026
Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World AnalysisOlga Demska, Jean-Christophe Ianotto, Marta Szandruk-Bender, et al.
Contemporary Oncology (Poznan, Poland)|October 18, 2024
Characteristics and outcomes of patients with lymphoma who developed therapy-related acute myeloid leukemia or myelodysplastic syndrome - a retrospective analysis of the Polish Adult Leukemia GroupAleksandra Gołos, Damian Mikulski, Monika Grobelska-Kowalik, et al.
Frontiers in Oncology|June 5, 2024
A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experienceMagdalena Karasek, Anna Armatys, Marek Skarupski, et al.
Ejhaem|December 5, 2022
Risk-adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosisNaveen Pemmaraju, Claire Harrison, Vikas Gupta, et al.
Acta Oncologica (Stockholm, Sweden)|August 4, 2021
Primary cutaneous indolent B-cell lymphomas - a retrospective multicenter analysis and a review of literatureMagdalena Olszewska-Szopa, Marta Sobas, Kamel Laribi, et al.
Thrombosis and Haemostasis|January 8, 2024
DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational StudyAdrián Segura-Díaz, Ruth Stuckey, Yanira Florido, et al.
Haematologica|November 13, 2008
Concordance of assays designed for the quantification of JAK2V617F: a multicenter studyEric Lippert, François Girodon, Emma Hammond, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 17, 2022
Analysis of Predictive Factors for Early Response to Ruxolitinib in 320 Patients with Myelofibrosis From the Polish Adult Leukemia Group (PALG) RegistryJoanna Góra-Tybor, Aleksandra Gołos, Damian Mikulski, et al.
Pageof 5